Scopus BioPharma to Present at the LD Micro Main Event

NEXT STORY
October is Breast Cancer Awareness Month – BriaCell is Advancing the Fight with its Immunotherapy
PREV STORY
Journey Medical Corporation Appoints Ernest De Paolantonio as Chief Financial Officer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

RECORDATI ANNOUNCES GROWTH IN THE FIRST NINE MONTHS 2019. REVENUES +8.6%, EBITDA +7.8%, OPERATING INCOME +4.9%, NET INCOME +6.6%. INTERIM DIVIDEND € 0.48 (+6.7%).

author_avatar
NASDAQ Market News

Novartis announces NEJM publication of three pivotal trials showing durable and potent efficacy of inclisiran, an investigational first-in-class siRNA cholesterol-lowering therapy

author_avatar
NASDAQ Market News

Apexigen and the Nordic Society of Gynaecological Oncology – Clinical Trial Unit Announce Collaborative Phase 2 Study of Sotigalimab (APX005M) in Combination Therapy for Ovarian Cancer

author_avatar
NASDAQ Market News